Abstract
Immune checkpoints are intensively investigated as targets in cancer therapy. T-cell immunoreceptor with immunoglobulin (Ig) and ITIM domains (TIGIT) ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
